Related references
Note: Only part of the references are listed.Regulation of AID, the B-cell genome mutator
Celia Keim et al.
GENES & DEVELOPMENT (2013)
Antibody-Dependent Cell-Mediated Virus Inhibition Antibody Activity Does Not Correlate With Risk of HIV-1 Superinfection
Donald N. Forthal et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2013)
Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity
Margaret E. Ackerman et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Characterization of Humoral and Cellular Immune Responses Elicited by a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine in Healthy Adults (IPCAVD 001)
Dan H. Barouch et al.
JOURNAL OF INFECTIOUS DISEASES (2013)
Enhanced Phagocytic Activity of HIV-Specific Antibodies Correlates with Natural Production of Immunoglobulins with Skewed Affinity for FcγR2a and FcγR2b
Margaret E. Ackerman et al.
JOURNAL OF VIROLOGY (2013)
A Nonfucosylated Variant of the anti-HIV-1 Monoclonal Antibody b12 Has Enhanced FcγRIIIa-Mediated Antiviral Activity In Vitro but Does Not Improve Protection against Mucosal SHIV Challenge in Macaques
Brian Moldt et al.
JOURNAL OF VIROLOGY (2012)
Replicating Adenovirus-Simian Immunodeficiency Virus (SIV) Recombinant Priming and Envelope Protein Boosting Elicits Localized, Mucosal IgA Immunity in Rhesus Macaques Correlated with Delayed Acquisition following a Repeated Low-Dose Rectal SIVmac251 Challenge
Peng Xiao et al.
JOURNAL OF VIROLOGY (2012)
Altered distribution of mucosal NK cells during HIV infection
M. Sips et al.
MUCOSAL IMMUNOLOGY (2012)
Vaccine protection against acquisition of neutralization-resistant SIV challenges in rhesus monkeys
Dan H. Barouch et al.
NATURE (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial
Barton F. Haynes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
HIV vaccine development: Challenges and opportunities towards solving the HIV vaccine-neutralizing antibody problem
Wayne C. Koff
VACCINE (2012)
SIVmac239 MVA vaccine with and without a DNA prime, similar prevention of infection by a repeated dose SIVsmE660 challenge despite different immune responses
Lilin Lai et al.
VACCINE (2012)
ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
Michael D. Alpert et al.
PLOS PATHOGENS (2012)
IgG2 inhibits HIV-1 internalization by monocytes, and IgG subclass binding is affected by gp120 glycosylation
Donald N. Forthal et al.
AIDS (2011)
Multiple HIV-1-specific IgG3 responses decline during acute HIV-1: implications for detection of incident HIV infection
Nicole L. Yates et al.
AIDS (2011)
Structure and Function of Intercellular Junctions in Human Cervical and Vaginal Mucosal Epithelia
Caitlin D. Blaskewicz et al.
BIOLOGY OF REPRODUCTION (2011)
Anti-Helicobacter pylori antibodies in cervical mucus: a new cause of infertility
Guido Ambrosini et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2011)
Immunization with HIV-1 gp41 Subunit Virosomes Induces Mucosal Antibodies Protecting Nonhuman Primates against Vaginal SHIV Challenges
Morgane Bomsel et al.
IMMUNITY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Limited or no protection by weakly or nonneutralizing antibodies against vaginal SHIV challenge of macaques compared with a strongly neutralizing antibody
Dennis R. Burton et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Role of donor genital tract HIV-1 diversity in the transmission bottleneck
Debrah I. Boeras et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques
Izabela Bialuk et al.
VACCINE (2011)
IgG Subclass Profiles in Infected HIV Type 1 Controllers and Chronic Progressors and in Uninfected Recipients of Env Vaccines
Kaustuv Banerjee et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2010)
The Role of Antibodies in HIV Vaccines
John R. Mascola et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 28 (2010)
Superior In vivo Efficacy of Afucosylated Trastuzumab in the Treatment of HER2-Amplified Breast Cancer
Teemu T. Junttila et al.
CANCER RESEARCH (2010)
Multiple Vaccine-Elicited Nonneutralizing Antienvelope Antibody Activities Contribute to Protective Efficacy by Reducing both Acute and Chronic Viremia following Simian/Human Immunodeficiency Virus SHIV89.6P Challenge in Rhesus Macaques
Peng Xiao et al.
JOURNAL OF VIROLOGY (2010)
Enhanced cellular responses and environmental sampling within inner foreskin explants: implications for the foreskin's role in HIV transmission
K. M. Fahrbach et al.
MUCOSAL IMMUNOLOGY (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses
Pierre Bruhns et al.
BLOOD (2009)
Contribution of Nonneutralizing Vaccine-Elicited Antibody Activities to Improved Protective Efficacy in Rhesus Macaques Immunized with Tat/Env Compared with Multigenic Vaccines
Ruth H. Florese et al.
JOURNAL OF IMMUNOLOGY (2009)
Correlation of Vaccine-Elicited Systemic and Mucosal Nonneutralizing Antibody Activities with Reduced Acute Viremia following Intrarectal Simian Immunodeficiency Virus SIVmac251 Challenge of Rhesus Macaques
Rachmat Hidajat et al.
JOURNAL OF VIROLOGY (2009)
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Supachai Rerks-Ngarm et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Fc receptor-mediated antiviral antibodies
Donald N. Forthal et al.
CURRENT OPINION IN HIV AND AIDS (2009)
Antibody fucosylation differentially impacts cytotoxicity mediated by NK and PMN effector cells
Matthias Peipp et al.
BLOOD (2008)
Initial B-Cell Responses to Transmitted Human Immunodeficiency Virus Type 1: Virion-Binding Immunoglobulin M (IgM) and IgG Antibodies Followed by Plasma Anti-gp41 Antibodies with Ineffective Control of Initial Viremia
Georgia D. Tomaras et al.
JOURNAL OF VIROLOGY (2008)
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG fc
Robert M. Anthony et al.
SCIENCE (2008)
Modeling how many envelope glycoprotein trimers per virion participate in human immunodeficiency virus infectivity and its neutralization by antibody
Per Johan Klasse
VIROLOGY (2007)
Non-fucosylated therapeutic antibodies: the next generation of therapeutic antibodies
Katsuhiro Mori et al.
CYTOTECHNOLOGY (2007)
Fc receptor but not complement binding is important in antibody protection against HIV
Ann J. Hessell et al.
NATURE (2007)
Structural comparison of fucosylated and nonfucosylated Fc fragments of human immunoglobulin G1
Shigeki Matsumiya et al.
JOURNAL OF MOLECULAR BIOLOGY (2007)
Rhesus macaque polyclonal and monoclonal antibodies inhibit simian immunodeficiency virus in the presence of human or autologous rhesus effector cells
Donald N. Forthal et al.
JOURNAL OF VIROLOGY (2006)
Anti-inflammatory activity of immunoglobulin G resulting from Fc sialylation
Yoshikatsu Kaneko et al.
SCIENCE (2006)
Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells
Vincent Holl et al.
JOURNAL OF VIROLOGY (2006)
Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation
V Holl et al.
BLOOD (2006)
IgG subclass-independent improvement of antibody-dependent cellular cytotoxicity by fucose removal from Asn297-linked oligosaccharides
R Niwa et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals
JS Moore et al.
AIDS (2005)
Establishment of FUT8 knockout Chinese hamster ovary cells:: An ideal host cell line for producing completely defucosylated antibodies with enhanced antibody-dependent cellular cytotoxicity
N Yamane-Ohnuki et al.
BIOTECHNOLOGY AND BIOENGINEERING (2004)
Class and subclass selection in parasite-specific antibody responses
O Garraud et al.
TRENDS IN PARASITOLOGY (2003)
The absence of fucose but not the presence of galactose or bisecting N-acetylglucosamine of human IgG1 complex-type oligosaccharides shows the critical role of enhancing antibody-dependent cellular cytotoxicity
T Shinkawa et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Macrophage HIV-1 infection and the gastrointestinal tract reservoir
PD Smith et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2003)
Lack of fucose on human IgG1 N-linked oligosaccharide improves binding to human FcγRIII and antibody-dependent cellular toxicity
RL Shields et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Secretory component:: A new role in secretory IgA-mediated immune exclusion in vivo
A Phalipon et al.
IMMUNITY (2002)
Lipid rafts and HIV-1: from viral entry to assembly of progeny virions
SM Campbell et al.
JOURNAL OF CLINICAL VIROLOGY (2001)
Inflammation in autoimmunity: receptors for IgG revisited
HM Dijstelbloem et al.
TRENDS IN IMMUNOLOGY (2001)
Antibody from patients with acute human immunodeficiency virus (HIV) infection inhibits primary strains of HIV type 1 the presence of natural-killer effector cells
DN Forthal et al.
JOURNAL OF VIROLOGY (2001)
Share Paper
